Cargando…
Gene therapy for arthritis – where do we stand?
The successful use of biologicals in the treatment of rheumatoid arthritis, psoriatic arthritis and spondyloarthritis has had a major impact on the management of these conditions. The challenge in the development of gene therapy as an alternative to these current treatments is to demonstrate that su...
Autor principal: | Chernajovsky, Yuti |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297573/ https://www.ncbi.nlm.nih.gov/pubmed/16277696 http://dx.doi.org/10.1186/ar1823 |
Ejemplares similares
-
Topical therapy of psoriasis: Where do we stand?
por: Thappa, DM, et al.
Publicado: (2017) -
Hyperbaric oxygen therapy promotes neurogenesis: where do we stand?
por: Mu, Jun, et al.
Publicado: (2011) -
Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021) -
Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021) -
Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013)